EM1021d : Endometrium cancer and normal tissue array, including pathology grade, TNM and clinical stage (AJCC 8th edition) 102 cases/102 cores (cores size 1.5mm), replacing EM1021c
  • $270.00
  • Unstained
  • H&E
-+
Microarray Panel Endometrium carcinoma and normal tissue microarray, containing 97 cases of endometrioid adenocarcinoma, 5 uteral tissue, single core per case
Cores 102
TissueArray.Com Tissue Array EM1021d
Cases 102
Row number 8
Column number 13
Core Diameter (mm) 1.5
Thickness (µm) 5
Quality Control H&E and IHC confirmed
Tissue Array Type FFPE
Species Human
Applications Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page
Notes 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers.
Mouseover and click individual cores to view high resolution images.
Slide Label: TissueArray.Com Tissue Array
12345678910111213
AUteUteUteUteUteUteUteUteUteUteUteUteUte
BUteUteUteUteUteUteUteUteUteUteUteUteUte
CUteUteUteUteUteUteUteUteUteUteUteUteUte
DUteUteUteUteUteUteUteUteUteUteUteUteUte
EUteUteUteUteUteUteUteUteUteUteUteUteUte
FUteUteUteUteUteUteUteUteUteUteUteUteUte
GUteUteUteUteUteUteUteUteUteUteUteUteUte
HUteUteUteUteUteUteUteUteUteUteUte  
Legend: Ute - Uterus

- Malignant tumor (stage I), - Malignant tumor (stage IA), - Malignant tumor (stage IB), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIA), - Malignant tumor (stage IIIA2), - Malignant tumor (stage IIIC), - Malignant tumor (stage IIIC1), - Malignant tumor (stage IIIC2), - Normal tissue

Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos.
No.
Age
Sex
Organ/Anatomic Site
Pathology diagnosis
TNM
Grade
Stage
Type
Image
A1
1
35
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
A2
2
53
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
1
IA
Malignant
A3
3
52
F
Uterus
Endometrioid adenocarcinoma
T1aN1M0
1
IIIC1
Malignant
A4
4
54
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
A5
5
53
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
A6
6
50
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
A7
7
40
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
A8
8
61
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
A9
9
51
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
A10
10
40
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
1
IA
Malignant
A11
11
76
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
1
IA
Malignant
A12
12
51
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
A13
13
57
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
1
IA
Malignant
B1
14
65
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
B2
15
66
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
1
IA
Malignant
B3
16
62
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
B4
17
57
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
B5
18
58
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
B6
19
52
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
2
IA
Malignant
B7
20
58
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
B8
21
62
F
Uterus
Endometrioid adenocarcinoma
T1N0M0
1
I
Malignant
B9
22
53
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
1
IA
Malignant
B10
23
61
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
B11
24
58
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
B12
25
62
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
B13
26
61
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
1
IB
Malignant
C1
27
67
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
C2
28
70
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
C3
29
65
F
Uterus
Endometrioid adenocarcinoma
T3aN0M0
2
IIIA
Malignant
C4
30
57
F
Uterus
Endometrioid adenocarcinoma
T3aN2aM0
2
IIIC2
Malignant
C5
31
54
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
2
IA
Malignant
C6
32
52
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
C7
33
53
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
2
IA
Malignant
C8
34
30
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
C9
35
64
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
C10
36
55
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
C11
37
56
F
Uterus
Endometrioid adenocarcinoma
T2N0M0
2
II
Malignant
C12
38
40
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
C13
39
66
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D1
40
52
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D2
41
71
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D3
42
49
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
2
IA
Malignant
D4
43
51
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D5
44
60
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
D6
45
56
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D7
46
54
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D8
47
55
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D9
48
70
F
Uterus
Endometrioid adenocarcinoma
T3aN0M0
2
IIIA2
Malignant
D10
49
63
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D11
50
50
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D12
51
56
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
D13
52
51
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E1
53
60
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E2
54
64
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
E3
55
53
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
E4
56
52
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E5
57
60
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E6
58
64
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E7
59
71
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E8
60
57
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E9
61
54
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E10
62
64
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E11
63
46
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
E12
64
73
F
Uterus
Endometrioid adenocarcinoma(sparse)
T1bN0M0
2
IB
Malignant
E13
65
61
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
F1
66
62
F
Uterus
Endometrioid adenocarcinoma
T1bN1M0
2
IIIC
Malignant
F2
67
51
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
F3
68
56
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
2
IB
Malignant
F4
69
63
F
Uterus
Endometrioid adenocarcinoma with squamous differentiation
T1bN0M0
3
IB
Malignant
F5
70
53
F
Uterus
Endometrioid adenocarcinoma with squamous differentiation
T1bN0M0
3
IB
Malignant
F6
71
54
F
Uterus
Endometrioid adenocarcinoma
T2N0M0
3
II
Malignant
F7
72
51
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
F8
73
56
F
Uterus
Endometrioid adenocarcinoma
T3aN0M0
3
IIIA
Malignant
F9
74
64
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
F10
75
53
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
F11
76
48
F
Uterus
Endometrioid adenocarcinoma
T2N0M0
3
II
Malignant
F12
77
61
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
F13
78
74
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
G1
79
57
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
G2
80
54
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
3
IA
Malignant
G3
81
60
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
G4
82
78
F
Uterus
Endometrioid adenocarcinoma
T3aN0M0
3
IIIA
Malignant
G5
83
47
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
G6
84
48
F
Uterus
Endometrioid adenocarcinoma
T3N0M0
3
III
Malignant
G7
85
33
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
G8
86
46
F
Uterus
Endometrioid adenocarcinoma
T1aN0M0
3
IA
Malignant
G9
87
62
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
G10
88
56
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
G11
89
56
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
G12
90
63
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
G13
91
53
F
Uterus
Endometrioid adenocarcinoma
T2N0M0
3
II
Malignant
H1
92
44
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
H2
93
54
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
H3
94
55
F
Uterus
Endometrioid adenocarcinoma
T1bN0M0
3
IB
Malignant
H4
95
62
F
Uterus
Endometrioid adenocarcinoma with squamous differentiation
T1bN0M0
3
IB
Malignant
H5
96
73
F
Uterus
Endometrioid adenocarcinoma with squamous differentiation
T1bN0M0
3
IB
Malignant
H6
97
65
F
Uterus
Endometrioid adenocarcinoma with squamous differentiation
T1bN0M0
3
IB
Malignant
H7
98
27
F
Uterus
Endometrial tissue
-
-
-
Normal
H8
99
48
F
Uterus
Endometrial tissue
-
-
-
Normal
H9
100
18
F
Uterus
Endometrial tissue
-
-
-
Normal
H10
101
48
F
Uterus
Endometrial tissue
-
-
-
Normal
H11
102
50
F
Uterus
Endometrial tissue
-
-
-
Normal
Find overlapping cases with this tissue array:
 

Write a review

Please login or register to review
 
  • Product Code: EM1021d
  • Availability: In Stock

Tags: Stage (TNM), With normal control (), Single core per case